
Personalized and Predictive Insulin Dosing Across the Healthcare Enterprise
Monarch Medical Technologies, the maker of the EndoTool Glucose Management System, is the leading provider of precision insulin dosing technology for improved patient outcomes.
"*" indicates required fields

Precision Medicine for Inpatient Glycemic Management
Proven, patented algorithms that model, predict and adapt dosing recommendations to each patient and their individual response to insulin, for more precise, safer therapy.
Hospitals using EndoTool IV have demonstrated better patient outcomes, including:
See Why Customers Love EndoTool

WHY GLYCEMIC MANAGEMENT MATTERS
Learn why adopting best practices in glycemic management is vital to high-quality patient care.
ENDOTOOL EVIDENCE LIBRARY
Explore clinical research studies demonstrating the safety and efficacy of EndoTool.

Spotlight
Check out the latest news and resources from our internal teams and our users!

eBook
Spotlight on New CMS Measures for Inpatient Glycemic Quality
What are you doing to prepare? This eBook will help you understand high-level specifications for new CMS measures effective January 1, 2023 as well as a few key preplanning essentials to ensure a successful implementation.
EVIDENCE

Safety of EndoTool Versus Fixed-Dose Insulin Infusions for DKA or HHS in the Emergency Department
This retrospective study compares the safety of EndoTool glucose management software to a standard fixed-dose insulin infusion protocol for patients presenting to an emergency department with DKA or HHS.
Video

Spectrum Health Improves Inpatient Glucose Control with EndoTool
In this video, clinical leaders at Spectrum Health describe why they adopted a computer-based approach, the multidisciplinary team that evaluated options, and ultimately how EndoTool has helped improve patient care and essentially eliminate hypoglycemia.